Center for Medicare and Medicaid Services; Mobile PET; PET availability; Reimbursement; United States
Indexed keywords
ARTICLE;
COMPUTED TOMOGRAPHY SCANNER;
CONTROLLED STUDY;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE FACILITY;
HUMAN;
INFORMATION PROCESSING;
INTERNET;
POPULATION RESEARCH;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
UNITED STATES;
EDITORIAL;
HOSPITAL;
HOSPITAL EQUIPMENT;
STATISTICS;
UTILIZATION REVIEW;
EQUIPMENT AND SUPPLIES, HOSPITAL;
HOSPITALS;
HUMANS;
INTERNET;
POSITRON-EMISSION TOMOGRAPHY;
UNITED STATES;
FDG PET detection of mild cognitive impairment with the cognitive decline index
Abstract
J Patterson D Lilien K Tainter et al. 2004 FDG PET detection of mild cognitive impairment with the cognitive decline index Biol Psychiatry 55 8-S1 54S Abstract
Expanded coverage of positron emission tomography (PET) scans and related claims processing changes
Department of Health and Human Services (DHHS). Health Care Financing Administration Publication 60AB. Transmittal AB-01-54. April 10
Department of Health and Human Services (DHHS) (2001). Expanded coverage of positron emission tomography (PET) scans and related claims processing changes. Health Care Financing Administration Publication 60AB. Transmittal AB-01-54. April 10
(2001)
3
25144518684
Decision memo for positron emission tomography (FDG) and other neuroimaging devices for suspected dementia
Center for Medicare and Medicaid Services (CMS). CAG-00088R. Sept 15
Center for Medicare and Medicaid Services (CMS) (2004). Decision memo for positron emission tomography (FDG) and other neuroimaging devices for suspected dementia. CAG-00088R. Sept 15
(2004)
4
0035845499
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET)
10.1073/pnas.19104419811526211
MJ Leon De A Convit OT Wolf et al. 2001 Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/ poitron-emission tomography (FDG/PET) Proc Natl Acad Sci U S A 98 10966-10971 10.1073/pnas.191044198 11526211
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
EM Reiman RJ Caselli K Chen et al. 2001 Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proc Natl Acad Sci U S A 98 3334-3339 10.1073/pnas.061509598 1:CAS:528:DC%2BD3MXit1altrg%3D 11248079
GW Small LM Ercoli DH Silverman et al. 2000 Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Proc Natl Acad Sci U S A 97 6037-6042 10.1073/pnas.090106797 1:CAS:528:DC%2BD3cXjvFarsbs%3D 10811879
Hippocampal formation glucose metabolism and volume losses in MCI and AD
1:CAS:528:DC%2BD3MXltVCqtro%3D 11445252
S Santi De MJ Leon de H Rusinek et al. 2001 Hippocampal formation glucose metabolism and volume losses in MCI and AD Neurobiol Aging 22 529-539 1:CAS:528:DC%2BD3MXltVCqtro%3D 11445252
